Recent studies have shown that flavaglines can directly binds to PHB to inhibit the activation of PHB-mediated signaling pathways, consequently leading to inhibition of protein synthesis, cell cycle progression, and cell growth in cancer cells [12, 31, 32]. This evidence concerns the gene PHB1 and cancer.